SWG Grant-funded projects, 2024

In November and December of 2023, SWGs were invited to develop project ideas and apply for a 2024 SWG Grant. 

Applications  

We received 11 different applications from nine SWGs–two more applications than in 2022.  

Applications came from:  

• Immune Therapies for Hematologic Disorders SWG (one application)  
• Myelodysplastic Syndromes (MDS) SWG (three applications)  
• Infections in Hematology SWG (one application)  
• Granulocytes and Constitutional Marrow Failure Disorders SWG (one application)  
• EHA Lymphoma Group (one application)  
• Red Cells and Iron SWG (one application)  
• Myeloproliferative Neoplasms SWG (one application)  
• Pediatric Hematology SWG (one application)  
• Thrombocytopenia and Platelet Function Disorders SWG (one application)  

The winners  

 After careful consideration and much discussion, the SWG Committee selected the following applications to receive grant funding:  

• CAR NK-cells project (SWG on Immune Therapies for Hematologic Disorders)  
• European registry on inherited platelet disorders project (SWG on Thrombocytopenia and Platelet Function Disorders)  
• Long-lasting, late-onset, and chronic idiopathic neutropenia project (SWG on Granulocytes and Constitutional Marrow Failure Disorders)  

All applications were reviewed against our selection criteria, which is explained in detail on the SWG Grants page.  

The SWG Committee congratulates all the successful entries and thanks all groups for participating.